Press Releases

Date Title and Summary
Toggle Summary Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification
Expands Global Access to Exceptional Quality Diagnostic-like CT Images for Medical Care Teams Using the Radixact System SUNNYVALE, Calif. , June 10, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT ™ helical
Toggle Summary Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
More Than 40,000 Patients Treated with CyberKnife Radiosurgery Worldwide SUNNYVALE, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that its CyberKnife(R) Robotic Radiosurgery System has been used to treat
Toggle Summary Accuray Establishes Medical Affairs Function
Reflects Company's Ongoing Strategy of Clinically Driven Innovation to Improve Patient Care SUNNYVALE, Calif., Dec. 17, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has established a Medical
Toggle Summary Accuray Enters Partnership with Still River Systems
Accuray to Provide Robotic Patient Positioning System for Lower Cost Proton Therapy Solution SUNNYVALE, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has entered into a partnership with
Toggle Summary Accuray Enters into New Revolving Loan Agreement
New Loan Expected to Reduce Interest Costs by Approximately $2.0 Million Annually SUNNYVALE, Calif. , June 15, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it has closed a new $52 million senior secured revolving loan facility with MidCap Financial Trust .
Toggle Summary Accuray Enters into $40 Million Term Loan; Company Intends to Retire Principal Amount of February 2018 Convertible Notes with Cash at Maturity
Company Also Modifies Revolving Loan Agreement SUNNYVALE, Calif. , Dec. 21, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today it closed a new $40 million term loan with MidCap Financial Trust while concurrently reducing the borrowing facility under its existing revolving
Toggle Summary Accuray Enhances Capital Structure Through Convertible Debt Transactions
­Transactions Facilitate Reduction of Short-term Debt and Potential Dilution to Shareholders SUNNYVALE, Calif. , July 28, 2017 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) has entered into privately negotiated agreements with a limited number of existing holders of the company's outstanding
Toggle Summary Accuray Elevated to NASDAQ Global Select Market
Market Boasts Highest Listing Standards in the World SUNNYVALE, Calif., Jan. 3, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it has been named to the NASDAQ Global Select Market, the premier listing tier for
Toggle Summary Accuray Elects Net Share Settlement for 3.50% Series A Convertible Senior Notes Due 2018
Company will pay principal in cash and deliver shares for any excess conversion value SUNNYVALE, Calif. , Jan. 3, 2018 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) has made an irrevocable Net Share Settlement Election with respect to its 3.50% Series A Convertible Senior Notes due February
Toggle Summary Accuray Educates Radiation Oncology Practices on the Potential Impact of the Proposed Alternative Payment Model (RO-APM)
SUNNYVALE, Calif. , Sept. 19, 2019 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today published an informational guide designed to help radiation oncology practices understand the complexities of the much-anticipated proposed Medicare & Medicaid reimbursement changes.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.